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ABSTRACT
EndA is a sequence non-specific endonuclease that
serves as a virulence factor during Streptococcus
pneumoniae infection. Expression of EndA
provides a strategy for evasion of the host’s neutro-
phil extracellular traps, digesting the DNA scaffold
structure and allowing further invasion by
S. pneumoniae. To define mechanisms of catalysis
and substrate binding, we solved the structure of
EndA at 1.75A ˚ resolution. The EndA structure
reveals a DRGH (Asp-Arg-Gly-His) motif-containing
bba-metal finger catalytic core augmented by an
interesting ‘finger-loop’ interruption of the active
site a-helix. Subsequently, we delineated DNA
binding versus catalytic functionality using
structure-based alanine substitution mutagenesis.
Three mutants, H154A, Q186A and Q192A, exhibited
decreased nuclease activity that appears to be in-
dependent of substrate binding. Glu205 was found
to be crucial for catalysis, while residues Arg127/
Lys128 and Arg209/Lys210 contribute to substrate
binding. The results presented here provide the mo-
lecular foundation for development of specific anti-
biotic inhibitors for EndA.
INTRODUCTION
Streptococcus pneumoniae commonly colonizes the human
upper respiratory tract (1). However, when the delicate
balance between benign harboring of bacterial ﬂora and
deleterious microbial outgrowth is disrupted, invasive
pneumococcal disease (IPD) can result (2). IPD is one of
the leading causes of opportunistic infections in young
children, the elderly and in individuals immunocomprom-
ised due to cancer, diabetes or human immunodeﬁciency
virus infection (3–6). Though favorable outcomes are pri-
marily expected as a result of early detection and prompt
antibacterial therapy, severe complications of IPD include
bacteremia, meningitis and death (2,6,7,8).
Bacterial colonization in the lungs of infected individ-
uals triggers neutrophil recruitment to the site of infection
(9), resulting in extrusion of DNA/protein scaffolds
known as neutrophil extracellular traps [NETs (10)].
These ﬁlamentous NETs physically trap bacteria, leaving
them vulnerable to phagocytic attack and/or destruction
by NET-bound antimicrobial proteins located in the
NETs (9–12). To combat the innate immune response,
constitutive expression of membrane-bound DNA-entry
nuclease EndA (13) is instrumental for respiratory track
invasion and increased virulence of S. pneumoniae. EndA
localization to the outer face of the bacterial membrane
(14,15) enables its sequence non-speciﬁc nuclease activity
to destroy the NETs. EndA, a DNA/RNA endonuclease
(16), is normally associated with DNA degradation and
uptake during the biochemical state of competence,
further promoting S. pneumoniae pathogenicity through
gene transfer (13,17). By helping streptococci to establish
genetic diversity, EndA may inﬂuence the ability of this
organism to adapt to changing environmental conditions,
providing a signiﬁcant advantage during infection.
Nuclease digestion of the NETs’ DNA scaffold is
associated with increased bacterial migration from the
upper airway to the lungs, and in 20–30% of cases,
invasion into the bloodstream (8,18,19). Streptococcus
pneumoniae strains expressing EndA have been shown to
evade and destroy NETs, and cause more virulent,
invasive forms of pneumonia (18). The role of EndA as
a virulence factor in pneumococcal infection makes it an
attractive target for antimicrobial therapeutics. However,
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lence, the mechanism by which EndA degrades DNA
remains enigmatic, due in part to the lack of EndA
protein structural information. Furthermore, the toxicity
of recombinantly expressed enzymes (15,20) and the sub-
sequent inability to purify active nuclease have hampered
biochemical and mechanistic studies of EndA.
To deﬁne mechanisms by which DNA-entry nucleases
bind and degrade DNA substrates, we report the structure
and detailed mutagenesis of S. pneumoniae EndA. We en-
gineered an active site glycine substitution mutant,
EndA(H160G), which yielded quantiﬁable imidazole
rescue nuclease activity. Structural information, coupled
with imidazole rescue, allowed for biochemical character-
ization of EndA variants surrounding the active site,
delineating catalytic activity versus DNA substrate
binding. Based on these results, histidine-to-glycine sub-
stitution paired with imidazole rescue could be utilized as
an all-purpose strategy for expression, puriﬁcation and
biochemical characterization of other bba-metal ﬁnger
nucleases.
MATERIALS AND METHODS
Cloning, expression and puriﬁcation of EndA(H160A)
The sequence encoding Ala31-Gln274 of EndA(H160A)
from S. pneumoniae was cloned into the pET30M expres-
sion vector as described previously (20). EndA(H160A)
was expressed as a His-GST fusion protein in
Rosetta2(DE3) cells, overnight at 18 C. The cells were
pelleted by centrifugation, resuspended in 25mM Tris
pH 7.5, 500–750mM NaCl and lysed by sonication. The
soluble fraction was bound in-batch to glutathione
sepharose 4B resin and EndA(H160A) was cleaved from
the resin by TEV protease, overnight at 4 C. Uncleaved
fusion protein contaminants were removed by a brief in-
cubation with Ni-NTA agarose. Unbound protein was
concentrated and loaded onto a Superdex 200 16/60
column equilibrated with 25mM Tris pH 7.5, 75mM
NaCl. Peak fractions were collected and concentrated to
 50mg/ml.
Crystallization and data collection
EndA(H160A) was crystallized by mixing 1ml of protein
(51mg/ml) with 1ml of 0.1M Tris pH 7, 17% PEG8K,
0.2M MgCl2. Crystals were grown by sitting drop vapor
diffusion (21) at room temperature. The highest resolution
data set was obtained from a glutaraldehyde cross-linked
crystal. This crystal was transferred from the original drop
into a 3.5ml hanging drop containing 0.1M Tris pH 7,
75mM NaCl, 0.2M MgCl2 and 20% PEG8K (mother
liquor). The crystal was placed in a drop over a vapor
diffusion chamber containing a sitting drop bridge with
3.5ml of 25% glutaraldehyde and 500ml mother liquor for
8min at room temperature. The crystal was then soaked in
a solution containing 0.1M Tris pH 7, 75mM NaCl,
0.2M MgCl2, 20% PEG8K, 11.6mM trimethyl lead
acetate and 9.63mM triethyl lead acetate for 43h at
room temperature for potential phasing opportunities.
The soaked crystal was transferred to a cryoprotectant
(0.1M Tris pH 7, 75mM NaCl, 0.2M MgCl2, 20%
PEG8K, 15% ethylene glycol, 11.9mM trimethyl lead
acetate and 13.75mM triethyl lead acetate) in four steps,
then ﬂash frozen in liquid nitrogen and placed in a stream
of nitrogen gas cooled to  180 C. The data were collected
at Southeast Regional Collaborative Access Team
(SER-CAT) BM-22 beamline at the Advanced Photon
Source (Argonne National Laboratory), at a wavelength
of 0.94A ˚ , with the MAR225 area detector. The data were
processed at 1.75A ˚ , in space group P212121 using
HKL2000 (22) (Table 1). All attempts at solving the struc-
ture of EndA(H160A) using molecular replacement with
other DRGH nucleases as search models, heavy metal
soaking or multi-wavelength anomalous dispersion with
engineered selenomethionine-substituted protein failed to
provide useful phase information. The phase problem was
solved by crystallizing EndA as a MBP(wt)-
EndA(H160A) fusion protein (23) and using a partial
model of EndA(H160A) from this data to solve the
1.75A ˚ structure by molecular replacement
(Supplementary Data). The quality of the electron
density maps was improved by density modiﬁcation and
Table 1. Data collection and reﬁnement statistics
EndA(H160A)
a MBP(wt)-
EndA(H160A)
a,b
Data collection
Space group P212121 P21
Cell dimensions
a, b, c (A ˚ ) 67.96, 75.93, 90.78 53.63, 64.23, 89.88
a, b, g ( ) 90, 90, 90 90, 96.32, 90
Resolution (A ˚ ) 50–1.75 (1.78–1.75)
c 50–2.6 (2.69–2.60)
Unique reﬂections 46402 18270
Rsym (%) 9.7 (37.1) 12.9(39.2)
I / sI 26.51 (3.56) 9.8 (2.4)
Completeness (%) 96.8 (68.7) 97.2 (97.0)
Redundancy 13.6 (7.2) 4.3 (2.9)
Model reﬁnement
Resolution (A ˚ ) 50–1.75
No. reﬂections 45460
Rwork / Rfree
d 19.6/21.6
No. atoms
Protein 3285
Ions 7
Water 495
B-factors
Protein (MolA/MolB) 22.74/21.63
Ions (MolA/MolB) 16.71/18.89
Water 31.99
RMSD
Bond lengths (A ˚ ) 0.005
Bond angles ( ) 1.2
Ramachandran plot
Most favorable (%) 98.7
Allowed (%) 100
aA single crystal was used for data collection.
bData quality for MBP(wt)-H160A was insufﬁcient for complete struc-
ture solution and reﬁnement. Therefore, only the statistics for data
collection are included.
cValues in parentheses refer to the highest resolution shell.
dRwork= || Fobs| |Fcalc||/  |Fobs|, where Rfree is calculated for a
randomly chosen 5% of reﬂections, which were not used for structure
reﬁnement and Rwork is calculated for the remaining reﬂections.
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ment was performed in crystallographic reﬁnement
package (CNS) (24), and the resulting structure was used
as a starting model for iterative building using AutoBuild
(25) in PHENIX (26). About 420 amino acids for two
molecules of EndA(H160A) (86.1%) were built, with an
Rfree of 23%. The ﬁnal model for EndA(H160A) was
generated by iterative cycles of manual model building
and reﬁnement in O (27) and CNS (24) (Rfree 21.6%).
The reﬁned model for EndA(H160A) contains amino
acid residues Ser46-Tyr124 and Ser136-Gln274 in
molecule A and residues Lys43-Lys125 and
Ser134-Gln274 in molecule B (Table 1). No
glutaraldehyde cross-linkages or lead derivative molecules
were found in the density. Ramachandran statistics were
determined by MolProbity (28), with 98.7% of residues in
the favored regions, and 100% in allowed regions.
Generation of EndA(H160G) mutants
The H160G mutation in EndA was obtained by
site-directed mutagenesis, using pET30M-EndA(H160A)
as a template for the reaction. Additional mutants were
generated on the H160G background using the same
method. All EndA proteins were expressed and puriﬁed
as for EndA(H160A).
Nuclease activity assay
EndA proteins were diluted to 20nM in activity buffer
(20mM Tris, 10mM sodium acetate, 10mM MES,
25mM NaCl, 5mM MgCl2, pH 8) and incubated with
15ng/ml of supercoiled pBluescript SK(+) plasmid for
30–35min, in the presence or absence of 0.2M imidazole.
This concentration of imidazole was chosen for the reac-
tions, as all phases (supercoiled, nicked open circle,
linearized and degraded) of digestion are visible.
The reactions were quenched by addition of loading dye
containing EDTA. Samples were run on a 0.8% (w/v)
agarose gel, dissolved in 1  Tris–Acetate–EDTA buffer.
DNA species in the gel were visualized by ethidum
bromide staining, scanned with a Typhoon ﬂuorescence
imager and analyzed using ImageQuant. Nuclease
activity assays were performed in triplicate.
Single radial enzyme diffusion (SRED) assay
Agarose (1% w/v) was dissolved in activity buffer (20mM
Tris, 10mM sodium acetate, 10mM MES, 25mM NaCl,
5mM MgCl2, ±0.2M imidazole, pH 8) and high molecu-
lar weight salmon sperm DNA (30mg/ml) and ethidium
bromide (1mg/ml) were added immediately prior to
casting. EndA proteins were diluted to 5mg/mL in
activity buffer (20mM Tris, 10mM sodium acetate,
10mM MES, 25mM NaCl, 5mM MgCl2, ±0.2M imid-
azole, pH 8) and 1ml of each protein solution was placed
in a small well on the SRED plates. About 0.5ml of DNase
I (1 unit/ml) was added to each plate as a positive control.
The plates were incubated overnight at 37 C. Nuclease
activity is identiﬁed by visualization of a dark ‘halo’
around the well site, as seen under UV254nm illumination.
The relative extent of nuclease activity for each protein
was determined by measurement of the halo radius. This
experiment was performed in triplicate.
DNA-binding assays
A 24mer oligonucleotide (50-GCAAGGTGCGTGCAGC
CTTGGACC-30) was annealed to a complementary oligo-
nucleotide by denaturation and slow cooling. The
annealed DNA was mixed with 10mM EndA protein in
a 4:1 molar ratio (11.5mM Tris pH 8, 10mM MgCl2,
7.5mM NaCl) and incubated on ice at 4 C for 2h.
About 2ml of High Density Tris Borate-EDTA (TBE)
Loading Buffer was added to each sample, and 5mlo f
this mixture was loaded onto a 1% agarose/1% acryl-
amide gel in 0.25  TBE. DNA and protein species were
serially stained on the same gel with ethidium bromide and
SYPRO Orange, respectively and scanned using a
Typhoon ﬂuorescence imager. About 610nm band-pass
and 555nm band-pass emission ﬁlters were used to
detect the ethidium bromide and SYPRO Orange
signals, respectively.
RESULTS
Structural organization of EndA(H160A)
The nuclease domain (Ala31-Gln274) of EndA from
S. pneumoniae, that contained the inactivating H160A
mutation and also lacking the N-terminal membrane lo-
calization signal sequence, was crystallized and reﬁned as
summarized in Table 1 (PDB ID code 3OWV). A model
for molecular replacement of EndA was obtained by
crystallizing an N-terminal MBP ﬁxed-arm fusion with
the EndA nuclease domain and building a partial model
to the EndA density which contained the core structural
elements (see ‘Materials and Methods’ section, and
Supplementary Data). The ﬁnal structure for the EndA
nuclease domain was reﬁned through a combination of
automated and manual model building. The protein core
is comprised of a central b-sheet consisting of ﬁve antipar-
allel b-strands (b-strands 3,4,7,8 and 9, Figure 1 and
Supplementary Figure S1). The ‘front’ face of the
molecule contains the active site and putative
DNA-binding surface. b-strands 5/6 and a-helix D form
the bba-metal ﬁnger motif that creates the catalytic center
(Figures 1B and 2A). The ‘back’ face of the molecule
contains little secondary structure. Aside from a single
ordered loop between b-strands 2 and 3 traversing this
face, most of the sheet is exposed to solvent
(Supplementary Figure S2). Analysis of the electrostatic
surface of EndA underscores the small size of the active
site (Figure 1C and D), and reveals a fairly even distribu-
tion of positively and negatively charged residues on both
faces of the protein. Residues Asn126-Gly135 connecting
b-strands 4 and 5 are disordered in this structure, as in
other crystal forms we were able to obtain, and were not
included in the calculation of the electrostatic surface po-
tential. Mass spectrometric analysis of dissolved crystals
yielded a molecular weight consistent with the expected
protein construct size rather than proteolyzed fragments
(data not shown). Due to the exclusion of the putative
transmembrane domain (Leu9–Leu18), and the lack of
Nucleic Acids Research,2011, Vol.39, No. 7 2945overt hydrophobic patches on the protein surface, the
current structural information reveals little information
on the mechanism by which EndA associates with the
bacterial outer membrane.
Sequence comparison of EndA with other DRGH nu-
cleases using ClustalW (29) shows, at best 16.3% sequence
identity over all core residues with the SR nuclease from
Syncephalastrum racemosum (30) although this alignment
failed to align the DRGH motif properly. Structural
comparisons by the Dali server (31) demonstrate some
core features are conserved with the DRGH nucleases:
NucA (32,33), Serratia nuclease (34,35), and EndoG (36)
(Figure 2). The SM endonuclease from Serratia
marcescens showed the greatest similarity to EndA, with
an RMSD of 2.9A ˚ (over 137 out of 235 Ca atoms). In this
structure-based alignment, only 18.2% of the aligned
backbone atoms exhibited corresponding side chain
conservation (Supplementary Table S1). There is
minimal structural similarity with EndA beyond the
conserved structure of the central b-sheet and the
bba-Me motif which forms the active site (Figure 2A).
For example, EndA shows a distinguishable difference in
the location of its N-terminus, compared to that of the
other DRGH nucleases. For NucA, Serratia nuclease,
and EndoG, the N-terminal residues lie along the ‘back’
face of the molecule, covering hydrophobic residues from
the core b-sheet. However, in EndA, the N-terminus
lies on the ‘front’ face of the sheet, traveling via two
a-helices (A and B) to the ‘back’ face through a hydro-
phobic channel along the top of the sheet (Figure 1B and
Supplementary Figure S2). N-terminal a-helices A and B
appear to be crucial for proper protein folding, since con-
structs lacking these residues exhibited decreased protein
expression and stability. Another difference characterizing
the central b-sheet in EndA is the absence of a small
b-strand found in NucA (Tyr58-Val61) and EndoG
(Val87-His90) (Figure 2B and C, yellow star). In NucA
and EndoG, this b-strand lies slightly out of the plane of
the rest of the b-sheet, possibly protecting the sheet and
preventing unwanted edge-on aggregation (37). For
Serratia nuclease, this b-strand becomes an ordered loop
(Val21–Val24) that could serve a similar purpose. The
opposite edge of the sheet in EndA is protected by an
antiparallel strand-loop-strand motif (b-strands 1 and 2)
not seen in the other nucleases (Figure 2B, pink triangle).
Instead, there is a short helix protecting this side of the
sheet in Serratia nuclease (Phe200-Phe203), NucA
(Trp238–Tyr241), and EndoG (Ile275–Phe278).
One of the most notable differences between EndA
and other bba-Me nucleases is the ‘ﬁnger-loop’ interrup-
tion of a-helix D (Figure 2A). Interestingly, superpos-
ition of a-helix D from EndA with the same helix in
the Serratia nuclease [PDB ID 1G8T (35)] clearly shows
that the presence of the ‘ﬁnger-loop’ does not cause a
true break in the canonical hydrogen bonding network in-
dicative of a-helices, allowing a smooth transition across
the site of the extrusion. Conservation of the architecture
of a-helix D is likely critical as the catalytic residue which
coordinates the metal ion, immediately precedes the loop.
This residue from EndA, Asn191, superimposes precisely
with structurally homologous residues from NucA
Figure 1. Sequence and structure of EndA. (A) Sequence and second-
ary structural elements of EndA from S. pneumoniae. a-Helices are
indicated as blue rectangles and b-strands as green arrows. The
DRGH motif is boxed in gray. The position of the general base
(His160) is shown in red. Mutated residues involved in catalysis are
shown in pink. Residues likely involved in DNA substrate binding and/
or catalysis are shown in purple. The ‘ﬁnger-loop’ is shown in cyan.
Disordered regions are highlighted in yellow. (B) Ribbon diagram of
EndA, showing the ‘front face’ of the molecule that contains the active
site. Secondary structural elements are color-coded as in (A) and the
magnesium ion is colored purple. The positions of the termini and the
ends of the disordered loop are labeled. (C) Electrostatic surface po-
tential of the ‘front face’ of EndA, in the same orientation as in (B).
The surface was calculated using the Adaptive Poisson–Boltzmann
Solver tool in PyMOL (47). The potential ranges from  8kTe
 1
(red) to 8kTe
 1 (blue). The location of the active site is highlighted
by a yellow circle. (D) Electrostatic surface potential of the ‘back face’
of EndA [Disordered side chains lacking density were modeled onto the
EndA surface for panels (C) and (D).].
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(Asn185), despite the presence of the ‘ﬁnger-loop’.
Improved imidazole chemical rescue of nuclease activity
by structure-based mutagenesis
Historically,activewild-typeEndAispuriﬁeddirectlyfrom
S. pneumoniae or expressed in cell-free systems (15,20). In
contrast,bacterialexpressionoftheinactiveEndA(H160A)
variant yielded large amounts of extremely soluble
(>75mg/ml) and stable protein. Nuclease activity for
EndA(H160A) could be rescued by addition of imidazole
(38,39) using a plasmid conversion nuclease activity assay
(20). This assay measures conversion of supercoiled sub-
strate to nicked open circle, linear duplex or degraded frag-
ments. Nuclease activity was recovered in the presence of
imidazole, however, the extent of rescue was relatively low
(Figure 3). One goal of our crystallographic studies was to
use structural information from EndA(H160A) to develop
a platform from which more robust imidazole rescue ex-
periments could be performed, using easily expressed, cata-
lytically inactive nuclease variants.
Based on examination of the EndA(H160A) structure, it
appeared that an imidazole molecule substituting for his-
tidinein the catalytic center would create stericclashes with
the Cb of H160A when properly positioned for catalysis.
The modeled imidazole ring would lie within 1.5A ˚ of the
Cb, whereas, if the alanine were substituted with glycine,
the distance from its Ca to the imidazole (2.58A ˚ ) would
signiﬁcantly reduce the steric clash. We therefore
hypothesized that the extent of imidazole rescue could be
improved bysubstituting the alanine with aglycine residue.
The resulting H160G mutant behaved similarly to the
H160A mutant during expression and puriﬁcation, and
displayed excellent solubility. Nuclease assays measuring
conversion of a supercoiled plasmid substrate (15) to open
circle (nicked) or linear (containing double-strand DNA
breaks) showed that the H160G mutant exhibited substan-
tially increased imidazole-dependent nuclease activity,
compared to the H160A mutant (Figure 3, Table 2). This
observation is consistent with results seen for imidazole
rescue in other types of enzymes (40,41).
In order to determine the optimum concentration of
imidazole, the plasmid conversion assay was repeated
for EndA(H160G), titrating the imidazole concentration
from 10nM to 500mM. Conversion of supercoiled
plasmid to nicked open circle surpassed background
levels upon addition of 1mM imidazole and reached max-
imum levels at  10mM (Supplementary Figure S3A). At
this concentration, the plasmid substrate was completely
Figure 2. Comparison of bba-metal ﬁnger nuclease structures.
(A) Stereo superposition of the bba-metal ﬁnger motif from EndA
(blue) and Serratia nuclease [gray, PDB ID code 1G8T (34)]. Asn191
from EndA is drawn in ball-and-stick in blue, along with the hydrated
magnesium (Mg
2+ as a purple sphere, and water molecules in red).
(B) Stereo superposition of the structures of EndA from S. pneumoniae
(blue) and SM endonuclease from S. marcescens [gray, PDB ID
code 1G8T (34)]. The bba-metal ﬁnger motif is labeled in red. The
b-strand found in Serratia, NucA and EndoG that is lacking in
EndA is labeled with a yellow star. The strand-loop-strand protecting
the opposite side of the b-sheet in EndA is labeled with a pink triangle.
(C) Stereo superposition of the structures of SM endonuclease
from S. marcescens [gray, PDB ID code 1G8T (34)], NucA from
Anabaena sp. [green, PDB ID code 1ZM8 (31)] and EndoG from
Drosophila melanogaster [orange, PDB ID code 3ISM (35)]. The
b-strand found in Serratia, NucA and EndoG that is lacking in
EndA is labeled with a yellow star. For the dimeric EndoG and
Serratia nucleases, only the monomer is shown.
Figure 3. Plasmid conversion nuclease activity assay for EndA(H160A)
and EndA(H160G). The assay measures conversion of the supercoiled
plasmid substrate to nicked open circle or linear (double strand breaks).
The assay was performed in the presence of 200mM imidazole and
10mM MgCl2).
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of nuclease activity at imidazole concentrations higher
than 100mM appeared slightly less robust, likely due to
the high-ionic strength of the reaction buffer. Though
10mM imidazole yielded the most potent EndA(H160G)
nuclease activity, the 200mM concentration was chosen as
the optimal concentration for the plasmid conversion
assay, since all phases of the digestion (nicked open
circle, linearized and high-molecular weight degraded
oligonucleotides) are visible and readily quantiﬁable.
Divalent cation preference displayed by EndA(H160G)
Many bba-metal ﬁnger nucleases exhibit an interesting
evolutionary active site design, which is optimized to
bind a hydrated divalent cation (32,34–36). The structure
of EndA contains a bound magnesium ion coordinated by
Asn191, and ﬁve water molecules (Figure 4). This ion was
reﬁned as magnesium because of the high concentration of
MgCl2 (200mM) present in the crystallization buffer, the
octahedral coordination geometry and because the bond
distances (2.07–2.21A ˚ ) between the ion and the water
molecules were consistent with those expected from mag-
nesium. In order to determine whether EndA displays a
preference for certain divalent metal cations, the plasmid
conversion assay was performed in the presence of
200mM imidazole and 10mM of various cations.
Imidazole-rescued EndA(H160G) activity appears to
have little preference between Mg
2+ and Mn
2+, but
shows little detectable activity in the presence of Ca
2+ or
Zn
2+ (Supplementary Figure S3B).
Effects of alanine substitution mutagenesis on EndA
nuclease activity
Since the EndA(H160G) exhibited greatly increased
nuclease activity in imidazole rescue experiments,
relative to EndA(H160A), the greater dynamic range
available with the glycine substitution allowed for a
more precise measurement of small changes in catalytic
activity. Therefore, we used this mutant as a ‘background’
for evaluating the effects of additional mutations. These
mutants were then tested for levels of nuclease activity in
the plasmid conversion assay and the single-radial enzyme
diffusion (SRED) assay (42).
To date, attempts to crystallize EndA in the presence of
various DNA substrates have been unsuccessful. To de-
termine the residues involved in catalysis and DNA
binding outside of the canonical DRGH motif, DNA
from another bba-Metal ﬁnger nuclease—VVN from
Vibrio vulniﬁcus [PDB ID code 1OUP (43)]—was
superimposed into the active site of EndA (Figure 4)
based on the bba-Me motif. The superimposed DNA ﬁts
snugly into a shallow cleft on the surface of EndA, imme-
diately outside the active site (Figure 4A). It should be
noted that the disordered loop between b-strands 4 and
5 would likely lie in close proximity to the DNA, over the
small cavity containing the catalytic center (Figure 4A and
B). Upon detailed examination of the superimposed DNA
into the EndA(H160A) structure, we mutated several
residues in the immediate vicinity of the active site
Figure 4. Mutagenesis of catalytic and DNA-binding residues in the
active site of EndA. (A) Surface rendering of EndA, with the
modeled DNA substrate from the VVN nuclease [PDB ID code
1OUP (42)] superimposed in the active site. (B) Stereo ribbon
diagram of the active site of EndA, displaying the ‘ﬁnger-loop’
(cyan), catalytic residues (pink) and DNA-binding residues (purple)
targeted for mutagenesis. The disordered loop is drawn in dashed
yellow. Putative positions of Arg127 and Lys128 on the disordered
loop are shown as purple triangles. (C) Ribbon diagram of the
‘ﬁnger-loop’ position (cyan), relative to the putative position of a
bound DNA substrate (tan).
Table 2. Comparison of imidazole-rescued nuclease activity between
EndA H160A and H160G
Mutant Conversion to oc Conversion to linear Degraded
H160A 5.4±0.18%
a ND ND
H160G 22.29±1.25% 12.39±2.24% 58.92±2.51%
oc: open circle (nicked) plasmid; ND: not detected.
aThese nuclease activity assays were performed in triplicate, scanned
using a Typhoon ﬂuorescence imager (GE Healthcare), and analyzed
using ImageQuant (Molecular Dynamics, Sunnyvale, CA, USA).
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Glu205 and Arg209/Lys210) to alanine and evaluated
their effects on DNA substrate binding and/or catalysis.
We included N191A in our study as a negative control,
since that mutation was nearly as deactivating as alanine
substitution for His160 (20), which is proposed to act as
the general base (44). To elucidate the role of the
‘ﬁnger-loop’ in a-helix D (Figure 4C), we created alanine
substitution mutants for Glu196/Tyr197 and a deletion
mutant where residues Gln194-Thr199 were removed
from the construct (Loop). Given the ‘ﬁnger-loop’
position proximal to the putative DNA binding site, it is
tempting to speculate that this feature could play a role in
DNA substrate binding or recognition.
All alanine substitution mutants appeared indistin-
guishable from the original EndA(H160G) with regards
to solubility, stability and behavior during size exclusion
chromatography. Plasmid conversion nuclease activity
assays with imidazole rescue were performed for each
mutant, and evaluated with respect to EndA(H160G).
These assays showed that, as expected, the H160G/
N191A mutant displayed no detectable nuclease activity
assay (Figure 5A and B). Therefore, mutations made on
the H160G background, with the aid of imidazole rescue,
behave similarly to the same mutations on wildtype back-
ground. The H160G/E205A and H160G/R127A/K128A
mutations also had no detectable activity. H160G/
H154A and H160G/R209A/K210A had minimal activity
levels, while H160G/Q186A and H160G/Q192A were less
affected. H160G/N202A showed activity levels nearly
comparable to the original H160G alone. Surprisingly,
the ‘ﬁnger-loop’ mutants showed no signiﬁcant differences
from the H160G mutant, though the Loop variant
appeared slightly more active.
As independent conﬁrmation of these results, the
nuclease activity was tested using the SRED assay (42).
Equal amounts of the EndA(H160G) variants were
spotted onto agarose plates containing MgCl2,
high-molecular weight salmon sperm DNA, imidazole
and ethidum bromide. Since ethidum bromide ﬂuoresces
only when bound to undigested DNA (45,46), nuclease
digestion by the EndA variants results in decreased
Figure 5. Nuclease activity assays for EndA variants generated on the background of H160G. (A) Plasmid conversion nuclease activity assay for
EndA(H160G) variants generated on the background of H160G. Supercoiled plasmid substrate was incubated with EndA(H160G) variants in the
presence or absence of 200mM imidazole. The supercoiled substrate (sc) is ﬁrst nicked to create the open circle (oc) species, further nicking activity
eventually creates double-strand breaks, linearizing the plasmid. A high level of nuclease activity degrades the linearized substrate to small oligo-
nucleotide fragments, which can be visualized as smears. (B) Bar graph illustrating the relative levels of nuclease activity for the EndA(H160G)
variants. The error bars reﬂect the standard deviation for n=3 replicates of this experiment. (C) Single radial enzyme diffusion assay for
EndA(H160G) variants. A SRED agarose plate containing high molecular weight salmon sperm DNA, MgCl2 and ethidium bromide.
EndA(H160G) variants were spotted onto this plate in equal amounts. Nuclease digestion is visualized by a dark ‘halo’ around each injection
site. (D) Halo radii for each EndA(H160G) variant were measured, and are displayed on the bar graph as a ratio of the H160G background. The
error bars reﬂect the standard deviation for n=3 replications of this experiment.
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injection site. Enzymes with higher levels of nuclease
activity are easily differentiated by a larger ‘halo’
(Figure 5C and 5D). Results from the SRED assay are
consistent with those obtained from the plasmid conver-
sion assay.
Delineation of EndA(H160G) nuclease activity and DNA
substrate binding
In order to discover whether loss of nuclease activity could
be correlated with DNA substrate binding, an electro-
phoretic mobility shift assay was performed using all
EndA(H160G) variants (Figure 6). Due to its high pre-
dicted pI (9.51), native gel electrophoresis of
EndA(H160G) alone results in negligible migration of
the protein (Figure 6A, lane 2). A complex formed by
non-speciﬁc binding of the 24 base pair duplex DNA sub-
strate to the protein (Figure 6B) alters the pI, enabling its
migration toward the cathode. The DNA/protein
complexes formed in this assay appear to be relatively
unstable and of low afﬁnity, presenting as a low-molecular
weight smear migrating above the unbound DNA
(Figure 6B and C). This behavior is consistent with the
non-sequence speciﬁc nature of EndA interactions with
DNA. Mutations which are thought to undermine the
catalytic mechanism (H160G/N191A) would be expected
to exhibit ‘wildtype’ substrate binding, but no nuclease
activity. Interestingly, all variants except for the H160G/
R127A/K128A and H160G/R209A/K210A mutants were
capable of binding the DNA substrate to an extent similar
to that of the ‘background’ H160G mutant (Figure 6C).
These results suggest that residues Arg127/Lys128 and
Arg209/Lys210 are likely involved in substrate binding.
Conversely, the E205A mutation displays no alteration
in substrate binding, yet has no detectable nuclease
activity. Therefore, Glu205 appears to be crucial for
catalysis.
Due to the markedly deleterious effects of the H160G/
R127A/K128A and the H160G/R209A/K210A multiple
mutants, individual mutations for each residue were
created and analyzed for both DNA binding and
nuclease activity. All four individual mutations (H160G/
R127A, H160G/K128A, H160G/R209A and H160G/
K210A) exhibited greatly decreased nuclease activity
(Supplementary Figure S4A and B), though not to the
extent of the multiple mutations. Interestingly, the indi-
vidual mutants did not show as drastic of a reduction in
DNA binding (Supplementary Figure S4C–E), compared
to the two double mutants.
DISCUSSION
Previous biochemical studies with EndA from
S. pneumoniae have been guided primarily by sequence
alignments with other members of the nuclease superfam-
ily. EndA contains a DRGH motif speciﬁc to some
related nucleases. Residues of the DRGH motif
(Asp157, Arg158 and His160) have been substituted
with alanine, resulting in severely deleterious effects on
catalytic activity (20). Beyond alignments of select active
site motifs, however, low sequence conservation between
EndA and other DRGH nucleases has hindered efforts
to understand the function and behavior of this sequence
non-speciﬁc nuclease. Therefore, in this work, we present
the X-ray crystal structure of the bba-metal ﬁnger EndA
nuclease from S. pneumoniae, at 1.75A ˚ . Comparison of
this structure with other nucleases within the same family
reveals a conserved core b-sheet and bba-metal ﬁnger
architecture for the catalytic center. Aside from these
conserved secondary structural elements, there is
minimal similarity to other nuclease structures within
this superfamily.
The catalytic mechanism for EndA is likely to be similar
to that proposed for Serratia nuclease (34,35) and NucA
(32), whereby His160 positions and activates a catalytic
water molecule for nucleophilic attack on the scissile phos-
phate. Asn191 directly coordinates the catalytic metal ion
believed to be involved in stabilization of the charge
buildup at the transition state (Figure 7A). Based on
Figure 6. DNA-binding assays for EndA(H160G) variants. Equal
amounts of EndA(H160G) proteins were mixed with a 24 base pair
duplex DNA substrate under low salt conditions, then separated
using an electrophoretic mobility shift assay. (A) Protein-containing
species were stained with SYPRO Orange (blue, Sigma-Aldrich).
(B) Molecular species containing DNA were stained with ethidium
bromide (red) on the same gel. (C) Images showing DNA (red) and
protein (blue) were merged using ImageJ (48), highlighting the DNA/
protein complexes in purple.
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were substituted with alanine. Despite its putative location
within the DNA binding surface, Asn202 had no apparent
effect on either DNA binding or catalysis. N202A dis-
played nuclease activity indistinguishable from the
H160G background mutant. Residues His154, Gln186,
Gln192 and Glu205 were identiﬁed as being catalytically
relevant, the most crucial of these being Glu205. Based on
the structure, Glu205 is homologous to Glu163 from
NucA, Glu127 from Serratia nuclease and Glu195 from
EndoG. Glu205 forms hydrogen bonds with two of the
waters coordinating the magnesium ion, possibly aiding in
active site assembly for catalysis (Figure 7B). The struc-
ture revealed that Gln186 forms a hydrogen bond with
another of the coordinating water molecules. The
Q186A substitution was not as catalytically deleterious
as E205A, presumably related to the fact that Gln186
interacts with only one of the inner sphere water molecules
coordinating the divalent ion. Residues His154 and
Gln192 are positioned farther from the active site, in
what could be described as ‘second shell’ active site
residues. These residues form a hydrogen bond network,
which likely helps stabilize the position of Asn191, using
Asp157 of the DRGH motif as an intermediary
(Figure 7B).
In addition to catalytically important residues, we also
identiﬁed several residues that appear to be important for
binding of the DNA substrate. Double mutants R127A/
K128A and R209A/K210A exhibited severely diminished
nuclease activity that correlates with abolished DNA sub-
strate binding. Therefore, some of these residues appear to
be involved in binding of the DNA substrate. It is also
possible that either Arg127 or Lys128 could play a cata-
lytic role in stabilizing the transition state during phospho-
diester bond hydrolysis (Figure 7), similar to the putative
role of Arg93 in NucA (32). At present, determining which
of these residues is more likely to assume this role is dif-
ﬁcult, since Arg127 and Lys128 lie on a disordered loop
and their exact positions are not deﬁned. Furthermore,
individual alanine substitution of Arg127, Lys128,
Arg209 and Lys210 showed a more marked decrease in
catalytic activity, in contrast to DNA binding capability.
It appears likely that Arg127/Lys128 and Arg209/Lys210
act synergistically to bind the DNA for catalysis. This
study presents the ﬁrst reported incidence of structure-
driven mutagenesis resulting in severely abrogated
substrate binding by a nuclease in the bba-metal ﬁnger
superfamily. That substrate binding can be so greatly
inﬂuenced by so few residues is intriguing, given the rela-
tively non-speciﬁc interactions of EndA with DNA.
Interestingly, we could not determine a speciﬁc role for
the unusual ‘ﬁnger-loop’ interruption of a-helix D. The
E196A/Y197A and the Loop deletion mutants were
competent in both DNA substrate binding and in cataly-
sis. It is tempting to speculate that this loop could be
involved in substrate speciﬁcity—by sensing differences
in substrate structure—in delineation of endonucleolytic
versus exonucleolytic activity, or in protein–protein inter-
actions with other components of the DNA uptake
complex during competence.
To the best of our knowledge, structure-driven muta-
genesis of EndA has yielded the ﬁrst reported incidence of
catalytic versus DNA binding separation of function for a
bba-metal ﬁnger nuclease sequence non-speciﬁc nuclease.
This technique could also be applied to other members of
the bba-metal ﬁnger nuclease superfamily, which could
prove invaluable due to the lack of sequence conservation
between family members. Further characterization of the
differences between EndA and other sequence non-speciﬁc
nucleases will be critical for structure-based design of
speciﬁc small-molecule inhibitors as therapeutics for
S. pneumoniae infection.
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